1. Home
  2. CSPI vs ENTA Comparison

CSPI vs ENTA Comparison

Compare CSPI & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSPI
  • ENTA
  • Stock Information
  • Founded
  • CSPI 1968
  • ENTA 1995
  • Country
  • CSPI United States
  • ENTA United States
  • Employees
  • CSPI N/A
  • ENTA N/A
  • Industry
  • CSPI EDP Services
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSPI Technology
  • ENTA Health Care
  • Exchange
  • CSPI Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • CSPI 174.4M
  • ENTA 152.3M
  • IPO Year
  • CSPI 1987
  • ENTA 2013
  • Fundamental
  • Price
  • CSPI $17.31
  • ENTA $8.13
  • Analyst Decision
  • CSPI
  • ENTA Buy
  • Analyst Count
  • CSPI 0
  • ENTA 4
  • Target Price
  • CSPI N/A
  • ENTA $17.25
  • AVG Volume (30 Days)
  • CSPI 37.9K
  • ENTA 507.8K
  • Earning Date
  • CSPI 02-10-2025
  • ENTA 02-10-2025
  • Dividend Yield
  • CSPI 0.69%
  • ENTA N/A
  • EPS Growth
  • CSPI N/A
  • ENTA N/A
  • EPS
  • CSPI 0.02
  • ENTA N/A
  • Revenue
  • CSPI $55,514,000.00
  • ENTA $66,590,999.00
  • Revenue This Year
  • CSPI N/A
  • ENTA N/A
  • Revenue Next Year
  • CSPI N/A
  • ENTA N/A
  • P/E Ratio
  • CSPI $924.49
  • ENTA N/A
  • Revenue Growth
  • CSPI N/A
  • ENTA N/A
  • 52 Week Low
  • CSPI $10.76
  • ENTA $4.71
  • 52 Week High
  • CSPI $29.93
  • ENTA $17.80
  • Technical
  • Relative Strength Index (RSI)
  • CSPI 43.99
  • ENTA 77.82
  • Support Level
  • CSPI $17.22
  • ENTA $6.92
  • Resistance Level
  • CSPI $20.39
  • ENTA $8.76
  • Average True Range (ATR)
  • CSPI 1.56
  • ENTA 0.60
  • MACD
  • CSPI -0.32
  • ENTA 0.42
  • Stochastic Oscillator
  • CSPI 1.90
  • ENTA 93.05

About CSPI CSP Inc.

CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: